Call Us + 33 1 84 88 31 00

Article R5126-110 of the French Public Health Code

I.-For healthcare institutions which do not have an in-house pharmacy, medicinal products reserved for hospital use are supplied either by a pharmaceutical company in application of 8° of article R. 5124-45, or by an in-house pharmacy of a healthcare institution or a health cooperation grouping in accordance with 4° of article L. 5126-5. When the supply is provided by an in-house pharmacy, the conditions of this supply are set out…

Read More »

Article R5126-111 of the French Public Health Code

In healthcare establishments which do not have an in-house pharmacy and which carry out the activity of treating chronic renal failure covered by article R. 6123-54, the medicinal products, products and articles mentioned in article L. 4211-1 and sterile medical devices are held and dispensed under the responsibility of the pharmacist managing the in-house pharmacy of a healthcare establishment or a health cooperation grouping which has entered into an agreement…

Read More »

Article R5126-112 of the French Public Health Code

Dispensing pharmacists and persons legally authorised to replace, assist or second them may dispense within the establishments mentioned in 3° of article R. 5126-1 the medicinal products, products or articles mentioned in article L. 4211-1 and sterile medical devices under the conditions laid down in articles R. 5125-50 to R. 5125-52 , provided that, in the case of the medicinal products mentioned in article R. 5132-1, they have been prescribed…

Read More »

Article R5126-114 of the French Public Health Code

For the supply of maritime companies operating ships, in application of 4° of article L. 5126-5, pharmacies for internal use may supply pharmacies with medicines reserved for hospital use, on presentation of an order form under the conditions set by an order of the Minister for Health.

Read More »

Article R5127-1 of the French Public Health Code

The public health inspecting pharmacists carry out inspections of the pharmacies and dispensaries mentioned in articles L. 5125-1, L. 5125-19, L. 5126-1, L. 5126-8, L. 5126-9 and L. 5126-13, places where medicinal products are held by the doctors mentioned in article L. 4211-3 and by the natural and legal persons mentioned in articles R. 5124-2 and R. 5124-45, as well as the herbalist shops mentioned in article L. 4211-7.

Read More »

Article R5127-2 of the French Public Health Code

Applications submitted by public health inspecting pharmacists to the President of the Judicial Court pursuant to the second paragraph of article L. 1421-2 are exempt from the requirement to appear before a lawyer or a public or ministerial officer.

Read More »

Article R5127-3 of the French Public Health Code

The request for an extension of the consignment order referred to in the second paragraph of article L. 5127-2, presented by the public health inspecting pharmacists, is brought before the president of the judicial court within whose jurisdiction the place where the products have been consigned is located or before the magistrate delegated for this purpose, who is seised without formality. The holder of the consigned products is notified by…

Read More »

Article R5127-4 of the French Public Health Code

Except in the cases provided for in article R. 5127-13, a sample consists of three samples, one left with the owner or holder of the product, the second destined for the laboratory competent to carry out the analyses and the third retained by the agent who took the sample.

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.